Evidence map›Paper›PMID 31321887›Full record

Trial reportJournal of the International AIDS Society2019

Index participant characteristics and HIV assisted partner services efficacy in Kenya: results of a cluster randomized trial.

Sarah J Masyuko, Peter K Cherutich, Marielle G Contesse, Peter M Maingi, Beatrice M Wamuti, Paul M Macharia, David E Bukusi, Felix A Otieno, Hans Ml Spiegel, Matthew D Dunbar and 3 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of the International AIDS Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Sarah J MasyukoNational AIDS and STI Control Program, Ministry of Health, Nairobi, Kenya.
Peter K CherutichDepartment of Preventive and Promotive Health Services, Ministry of Health, Nairobi, Kenya.
Marielle G ContesseDepartment of Epidemiology, University of Washington, Seattle, WA, USA.
Peter M MaingiVCT and HIV Prevention Unit, Kenyatta National Hospital, Nairobi, Kenya.
Beatrice M WamutiDepartment of Research and Programs, Kenyatta National Hospital, Nairobi, Kenya.
Paul M MachariaNational AIDS and STI Control Program, Ministry of Health, Nairobi, Kenya.
David E BukusiVCT and HIV Prevention Unit, Kenyatta National Hospital, Nairobi, Kenya.
Felix A OtienoDepartment of Research and Programs, Kenyatta National Hospital, Nairobi, Kenya.
Hans Ml SpiegelDepartment of Health and Human Services, Kelly Government Solutions, Contractor to National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA.
Matthew D DunbarDepartment of Computer Science and Demography, University of Washington, Seattle, WA, USA.
Matthew R GoldenDepartment of Medicine, University of Washington, Seattle, WA, USA.
Barbra A RichardsonDepartment of Global Health, University of Washington, Seattle, WA, USA.
Carey FarquharDepartment of Global Health, University of Washington, Seattle, WA, USA.

Funding

Promoting Diversity, Equity, and Inclusivity in Research Training to Optimize HIV Prevention and TreatmentD43TW009580 · FIC · UNIVERSITY OF WASHINGTON · PI CAREY FARQUHAR, John Kinuthia · 2013 to 2026
$4.8M
Women and HIV: Translation of Research into Practice-WLHIV Post-Graduate Research FellowshipD43TW009783 · FIC · UNIVERSITY OF WASHINGTON · PI Elizabeth Anne BUKUSI, CAREY FARQUHAR · 2015 to 2026
$4.1M
Assisted Partner Notification to Augment HIV Treatment and Prevention in KenyaR01AI099974 · NIAID · UNIVERSITY OF WASHINGTON · PI FARQUHAR, CAREY · 2012 to 2014
$2.6M
FIC NIH HHS D43 TW009580FIC NIH HHS D43 TW009783NIAID NIH HHS R01 AI099974
6 · The paper itself

Abstract

introductionWe have previously demonstrated that assisted partner services (aPS) increases HIV testing and case finding among partners of persons living with HIV (PLHIV) in a cluster randomized trial in Kenya. However, the efficacy of aPS may vary across populations. In this analysis, we explore differences in aPS efficacy by characteristics of index participants.

methodsEighteen HIV testing sites were randomized to immediate versus 6-week delayed aPS. Participants were PLHIV (or index participants) and their sexual partners. Partners of index participants were contacted for HIV testing and linked to care if HIV positive. Primary outcomes were the number of partners per index participant who: 1) tested for HIV, 2) tested HIV positive and 3) enrolled in HIV care. We used generalized estimating equations to assess differences in aPS efficacy by region, testing location, gender, age and knowledge of HIV status.

resultsFrom 2013 to 2015, the study enrolled 1119 index participants, 625 of whom were in the immediate group. These index participants named 1286 sexual partners. Immediate aPS was more efficacious than delayed aPS in promoting HIV testing among partners in high compared to low HIV prevalence regions (Nyanza incidence rate ratio (IRR) 7.2; 95% confidence interval (CI) 5.4, 9.6 vs. Nairobi/Central IRR 3.4 95% CI 2.3, 4.8). Higher rates of partner HIV testing were also observed for index participants in rural/peri-urban compared to urban sites (IRR 6.6; 95% CI 4.5, 9.6 vs. IRR 3.5 95% CI 2.5, 5.0 respectively), for female versus male index participants (IRR 5.8 95% CI 4.2, 7.9 vs. IRR 3.7; 95% CI 2.4, 5.8 respectively) and for newly diagnosed versus known HIV-positive index participants (IRR 6.0 95% CI 4.2, 8.7 vs. IRR 3.3; 95% CI 2.0, 7.7 respectively). Providing aPS to female versus male index participants also had a significantly higher HIV case finding rate (IRR 9.1; 95% CI 4.0, 20.9 vs. IRR 3.2 95% CI 1.7, 6.0 respectively.)

conclusionsWhile it is known that aPS promotes increases in HIV testing and case finding, this is the first study to demonstrate significant differences in aPS efficacy across characteristics of the index participant. Understanding these differences and their drivers will be critical as aPS is brought to scale in order to ensure all PLHIV have access to these services.

Indexed as

Diagnostic ServicesDisease NotificationSexual PartnersAdultFemaleHIV InfectionsHumansKenyaMalePrevalenceTime FactorsAfricaclinical trialsHIV preventionpartner services

Identifiers

PMID31321887
PMCPMC6639668

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.